Cigarette Smoking-Related Carcinoma Clinical Trial
Official title:
An mHealth Mood Management Tool to Improve Population-Level Cessation
Verified date | March 2024 |
Source | Fred Hutchinson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This phase I trial investigates a new smartphone application (called Actify) for improving population-level smoking cessation and mood management. Actify delivers behavioral activation therapy for depression as part of a smoking cessation intervention and will be compared to another smoking cessation smartphone application that is based on current clinical practice guidelines. Participants will be randomly assigned to receive one of two smartphone applications and accompanying text notifications to help with quitting smoking and improved mood.
Status | Completed |
Enrollment | 242 |
Est. completion date | April 12, 2023 |
Est. primary completion date | December 19, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Current smoker, averaging at least 5 cigarettes/day for the last 30 days - Interested in quitting smoking in the next 30 days - Experience downloading and using one or more apps on their smartphone - Either screens negative (Patient Health Questionnaire - 9 Item [PHQ-9] score 0-4) for depression or screens positive for mild to moderate current depressive symptoms (PHQ-9 score 5-19) - Willing and able to complete all study activities - Comfortable reading and writing in English - Have a mobile data plan and/or access to WiFi to support the use of the Actify app - Reside in the US - Have a smartphone either an iPhone (running iOS version 11 or higher) or an Android phone (running version 5.0 or higher) Exclusion Criteria: - Currently receiving behavioral treatment for depression (e.g., psychotherapy) - Current use of a depression app - Severe depression (PHQ-9 >= 20) - Receiving other treatment for smoking cessation - Previous use of the QuitGuide app - Current or recent (within the past year) enrollment in a Fred Hutch smoking cessation study - Employees/family of investigator or study center - Member of the same household as another participant - Woman who is pregnant or breastfeeding, or planning to become pregnant - Currently incarcerated - Is ineligible per fraud prevention protocol |
Country | Name | City | State |
---|---|---|---|
United States | Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
Fred Hutchinson Cancer Center | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall Satisfaction With Assigned Treatment on the Treatment Satisfaction Survey | Overall treatment satisfaction is reported on a Likert-type scale, with response choices ranging from "not at all=1" to "very much=5". Higher values are associated with higher level of satisfaction. | At 8 weeks post-randomization | |
Primary | Application (App) Utilization | Number of app openings during the 8-week treatment period. | At 8 weeks post-randomization | |
Secondary | Biochemically-confirmed 30-day PPA From Smoking | Self-reported 30-day smoking abstinence at 8 weeks, confirmed via expired carbon monoxide (CO<6ppm) | At 8 weeks post-randomization | |
Secondary | Self-reported 30-day PPA From Smoking | Self-reported 30-day abstinence on the survey question of "Have you smoked at all, even a puff, in the last 30 days?" | At 6 months post-randomization | |
Secondary | Biochemically-confirmed 30-day PPA From Smoking | Self-reported 30-day smoking abstinence at 6 months, confirmed via expired carbon monoxide (CO<6 ppm) | At 6 months post-randomization | |
Secondary | Self-reported 7-day PPA From Smoking | Self-reported 7-day abstinence on the survey question of "When was the last time you smoked, or even tried, a cigarette?" | At 8 weeks post-randomization | |
Secondary | Biochemically Confirmed 7-day PPA From Smoking | Self-reported 7-day abstinence from smoking, confirmed via expired carbon monoxide (CO < 6ppm) | At 8 weeks post-randomization | |
Secondary | Self-reported 7-day PPA From Smoking | Self-reported 7-day abstinence on the survey question of "When was the last time you smoked, or even tried, a cigarette?" | At 6 months post-randomization | |
Secondary | Biochemically Confirmed 7-day PPA From Smoking | Self-reported 7-day abstinence from smoking, confirmed via expired carbon monoxide (CO < 6ppm) | At 6 months post-randomization | |
Secondary | Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes | Self-reported 30-day abstinence on the survey questions of "Have you smoked at all, even a puff, in the last 30 days?" & "In the last 30 days, how often did you use any kind of e-cigarette or vaping product?" & "In the last 30 days, how often did you use any other tobacco products such as chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, and kreteks?" | At 8 weeks post-randomization | |
Secondary | Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes | Self-reported abstinence from cigarettes and other non-medicinal nicotine/tobacco products, including e-cigarettes, confirmed via at home saliva cotinine test and expired carbon monoxide (CO < 6ppm) | At 8 weeks post-randomization | |
Secondary | Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes | Self-reported 30-day abstinence on survey questions of "Have you smoked at all, even a puff, in the last 30 days?" & "In the last 30 days, how often did you use any kind of e-cigarette or vaping product?" & "In the last 30 days, how often did you use any other tobacco products such as chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, and kreteks?" | At 6 months post-randomization | |
Secondary | Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes | Self-reported abstinence from cigarettes and other non-medicinal nicotine/tobacco products, including e-cigarettes, confirmed via at home saliva cotinine test and expired carbon monoxide (CO < 6ppm) | At 6 months post-randomization | |
Secondary | Change in Depressive Symptoms Via Patient Health Questionnaire-8 (PHQ-8) | The Patient Health Questionnaire-8 (PHQ-8) is an assessment of depressive symptoms used to detect symptom changes over time as a result of treatment. The PHQ-8 asks the number of days in the past 2 weeks the respondent had experienced a particular depressive symptom. Possible answers are "not at all" or "several days" or "more than half the days" or "nearly every day," with points (0 to 3) assigned to each category. The scores for each item are summed to produce a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe. | Baseline to 8 weeks | |
Secondary | Self-reported 30-day Point Prevalence Abstinence (PPA) From Smoking | Self-reported 30-day abstinence on the survey question of "Have you smoked at all, even a puff, in the last 30 days?" | At 8 weeks post-randomization | |
Secondary | Change in Behavioral Activation Subscale Score on the Behavioral Activation for Depression Scale (BADS) | The Behavioral Activation for Depression Scale (BADS) is a 25-item scale used to track changes in behaviors hypothesized to underlie depression and specifically targeted for change by behavioral activation. BADS items are rated on a 7-point scale ranging from 0 (not at all) to 6 (completely). The behavioral activation subscale contains 7 items, with a scoring range of 0 to 42. Change scores reflect the value of the BADS behavioral activation subscale score at 8-week follow-up minus the baseline score. Positive change values indicate an increase in behavioral activation (i.e, an improvement), whereas negative scores indicate a decrease in behavioral activation. | Baseline to 8 weeks post-randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06038526 -
Evaluation of Canakinumab in High-Risk Former-Smokers
|
Phase 2 | |
Recruiting |
NCT05121051 -
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
|
Phase 2 | |
Not yet recruiting |
NCT06386432 -
EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico
|
N/A | |
Active, not recruiting |
NCT02964182 -
Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers
|
N/A | |
Completed |
NCT04510077 -
SmartQuit Program for Smoking Cessation
|
N/A | |
Recruiting |
NCT06230159 -
Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use
|
N/A | |
Completed |
NCT05455086 -
Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study
|
N/A | |
Recruiting |
NCT06010355 -
Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities
|
N/A | |
Completed |
NCT05236894 -
Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia Population
|
Early Phase 1 | |
Recruiting |
NCT05825001 -
Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers
|
N/A | |
Not yet recruiting |
NCT06213532 -
CONNECTing to LungCare
|
N/A | |
Recruiting |
NCT03856515 -
Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
|
N/A | |
Completed |
NCT03480373 -
Electronic Cigarette Use During Pregnancy
|
||
Not yet recruiting |
NCT06055231 -
PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis
|
Phase 1 | |
Active, not recruiting |
NCT04308759 -
An Innovative Conversational Agent (Quitbot) for Smoking Cessation
|
Phase 3 | |
Active, not recruiting |
NCT04972513 -
Impact of E-cigarette Use on the Body
|
||
Withdrawn |
NCT05024955 -
Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
|
||
Completed |
NCT05227027 -
Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation
|
N/A | |
Completed |
NCT04502524 -
Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans
|
Phase 1 | |
Completed |
NCT03402230 -
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers
|
Early Phase 1 |